TY  - GEN
AU  - Eisenbeis,Charles F
AU  - Grainger,Andrew
AU  - Fischer,Beth
AU  - Baiocchi,Robert A
AU  - Carrodeguas,Lester
AU  - Roychowdhury,Sameek
AU  - Chen,Lei
AU  - Banks,Amy L
AU  - Davis,Thomas
AU  - Young,Donn
AU  - Kelbick,Nicole
AU  - Stephens,Julie
AU  - Byrd,John C
AU  - Grever,Michael R
AU  - Caligiuri,Michael A
AU  - Porcu,Pierluigi
TI  - Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study
SN  - 1078-0432
PY  - 2005///0111
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Agents
KW  - Combined Modality Therapy
KW  - methods
KW  - Female
KW  - Humans
KW  - Immunotherapy
KW  - Interleukin-2
KW  - Killer Cells, Natural
KW  - immunology
KW  - Leukocytes
KW  - Leukocytes, Mononuclear
KW  - metabolism
KW  - Lymphoma, B-Cell
KW  - Lymphoma, Non-Hodgkin
KW  - Male
KW  - Mice
KW  - Mice, SCID
KW  - Middle Aged
KW  - Rituximab
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1158/1078-0432.CCR-04-0525
ER  -